Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies

By Kawana K.   Kawana Y.   Yoshikawa H.   Taketani Y.   Yoshiike K.   Kanda T.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1496-1502

Elsevier

Access to resources Recommend Favorite

Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV

By Fernandez I.M.   Golding H.   Benaissa-Trouw B.J.   de Vos N.M.   Harmsen M.   Nottet H.S.L.M.   Golding B.   Puijk W.C.   Meloen R.H.   Snippe H.   Kraaijeveld C.A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1936-1940

Elsevier

Access to resources Recommend Favorite

Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env

By Collado  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3123-3133

Elsevier

Access to resources Recommend Favorite

Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization

By Nagata T.   Higashi T.   Aoshi T.   Suzuki M.   Uchijima M.   Koide Y.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 105-114

Elsevier

Access to resources Recommend Favorite

Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice

By Takahashi A.   Ogasawara K.   Matsuki N.   Fujinaga K.   Nakaya T.   Ikuta K.   Auwanit W.   Honda M.   Fukui Y.   Sasazuki T.   Iwabuchi K.   Onoe K.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1537-1543

Elsevier

Access to resources Recommend Favorite